K. Dilger

667 total citations
9 papers, 425 citations indexed

About

K. Dilger is a scholar working on Genetics, Oncology and Pharmacology. According to data from OpenAlex, K. Dilger has authored 9 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in K. Dilger's work include Inflammatory Bowel Disease (5 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). K. Dilger is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). K. Dilger collaborates with scholars based in Germany, Austria and Israel. K. Dilger's co-authors include Ulrich Beuers, Roland Greinwald, Ralph Müeller, Klaus Herrlinger, Sieglinde Angelberger, Wolfgang Petritsch, Alexander Teml, Olga Shonová, Walter Reinisch and Simon Bar–Meir and has published in prestigious journals such as Gut, Clinical Pharmacology & Therapeutics and Alimentary Pharmacology & Therapeutics.

In The Last Decade

K. Dilger

9 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Dilger Germany	9	219	211	111	72	71	9	425
S Greenfield United Kingdom	11	134 0.6×	171 0.8×	123 1.1×	57 0.8×	60 0.8×	20	455
P. A. M. van Hees Netherlands	11	94 0.4×	140 0.7×	122 1.1×	39 0.5×	48 0.7×	13	346
Sandra E. Peterson United States	6	275 1.3×	371 1.8×	170 1.5×	26 0.4×	47 0.7×	9	567
Dennis R. Wong Netherlands	15	187 0.9×	338 1.6×	76 0.7×	393 5.5×	42 0.6×	41	786
J. R. Reynolds United Kingdom	12	127 0.6×	135 0.6×	186 1.7×	21 0.3×	39 0.5×	17	448
Sigrid Nelson Canada	9	264 1.2×	338 1.6×	164 1.5×	30 0.4×	76 1.1×	13	620
P.R. Dal Monte Italy	11	212 1.0×	149 0.7×	180 1.6×	19 0.3×	39 0.5×	29	468
H. J. Steinhardt Germany	8	293 1.3×	380 1.8×	242 2.2×	15 0.2×	36 0.5×	12	581
P. M. Hooymans Netherlands	15	214 1.0×	398 1.9×	76 0.7×	536 7.4×	32 0.5×	35	875
Guido Varoli Italy	13	304 1.4×	271 1.3×	121 1.1×	19 0.3×	11 0.2×	23	705

Countries citing papers authored by K. Dilger

Since Specialization

Citations

This map shows the geographic impact of K. Dilger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Dilger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Dilger more than expected).

Fields of papers citing papers by K. Dilger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Dilger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Dilger. The network helps show where K. Dilger may publish in the future.

Co-authorship network of co-authors of K. Dilger

This figure shows the co-authorship network connecting the top 25 collaborators of K. Dilger. A scholar is included among the top collaborators of K. Dilger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Dilger. K. Dilger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kruis, Wolfgang, Laimas Virginijus Jonaitis, Juris Pokrotnieks, et al.. (2010). Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis. Alimentary Pharmacology & Therapeutics. 33(3). 313–322. 63 indexed citations

Reinisch, Walter, Sieglinde Angelberger, Wolfgang Petritsch, et al.. (2010). Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut. 59(6). 752–759. 127 indexed citations

Ufer, Mike, K. Dilger, Igor Mosyagin, et al.. (2008). Influence of CYP3A4, CYP3A5, and ABCB1 Genotype and Expression on Budesonide Pharmacokinetics: A Possible Role of Intestinal CYP3A4 Expression. Clinical Pharmacology & Therapeutics. 84(1). 43–46. 21 indexed citations

Dilger, K., Dietmar Trenk, Martin Rössle, et al.. (2007). A clinical trial on absorption andN‐acetylation of oral and rectal mesalazine. European Journal of Clinical Investigation. 37(7). 558–565. 12 indexed citations

Dilger, K., Martin Alberer, Andreas Büsch, et al.. (2006). Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease. Alimentary Pharmacology & Therapeutics. 23(3). 387–396. 14 indexed citations

Deibert, Peter, K. Dilger, Christine Fischer, et al.. (2003). High variation of tioguanine absorption in patients with chronic active Crohn's disease. Alimentary Pharmacology & Therapeutics. 18(2). 183–189. 20 indexed citations

Dilger, K., et al.. (2003). Ursodeoxycholic acid — adverse effects and drug interactions. Alimentary Pharmacology & Therapeutics. 18(10). 963–972. 84 indexed citations

Sagir, Abdurrahman, et al.. (2003). Inhibition of Cytochrome P450 3A: Relevant Drug Interactions in Gastroenterology. Digestion. 68(1). 41–48. 31 indexed citations

Dilger, K.. (2000). Enzyme induction in the elderly: Effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone. Clinical Pharmacology & Therapeutics. 67(5). 512–520. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact